Image_1_HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion.JPEG
Background: Natural antisense long non-coding RNAs (lncRNAs) are regulatory RNAs transcribed from the opposite strand of either protein coding or non-coding genes, able to modulate their own sense gene expression. Hence, their dysregulation can lead to pathologic processes. Cancer is a complex class of diseases determined by the aberrant expression of a variety of factors, among them, the oncofetal chromatin architectural proteins High Mobility Group A (HMGA) modulate several cancer hallmarks. Thus, we decided to investigate the presence of natural antisense lncRNAs in HMGA1 and HMGA2 loci, and their possible involvement in gene expression regulation.
Methods: We used FANTOM5 data resources, FANTOM-CAT genome browser and Zenbu visualization tool, which employ 1,829 human CAGE and RNA-sequencing libraries, to determine expression, ontology enrichment, and dynamic regulation of natural antisense lncRNAs in HMGA1 and HMGA2 loci. We then performed qRT-PCR in different cancer cell lines to validate the existence of HMGA2-AS1 transcripts. We depleted HMGA2-AS1 transcripts with siRNAs and investigated HMGA2 expression by qRT-PCR and western blot analyses. Moreover, we evaluated cell viability and migration by MTS and transwell assays, and EMT markers by qRT-PCR and immunofluorescence. Furthermore, we used bioinformatics approaches to evaluate HMGA2 and HMGA2-AS1 correlation and overall survival in tumor patients.
Results: We found the presence of a promoter-associated lncRNA (CATG00000088127.1) in the HMGA1 gene and three antisense genes (RPSAP52, HMGA2-AS1, and RP11-366L20.3) in the HMGA2 gene. We studied the uncharacterized HMGA2-AS1 transcripts, validating their existence in cancer cell lines and observing a positive correlation between HMGA2 and HMGA2-AS1 expression in a cancer-derived patient dataset. We showed that HMGA2-AS1 transcripts positively modulate HMGA2 expression and migration properties of PANC1 cells through HMGA2. In addition, Kaplan-Meier analysis showed that high level of HMGA2-AS1 is a negative prognostic factor in pancreatic cancer patients.
Conclusions: Our results describe novel antisense lncRNAs associated with HMGA1 and HMGA2 genes. In particular, we demonstrate that HMGA2-AS1 is involved in the regulation of its own sense gene expression, mediating tumorigenesis. Thus, we highlight a new layer of complexity in the regulation of HMGA2 expression, providing new potential targets for cancer therapy.
History
References
- https://doi.org//10.1126/science.1117806
- https://doi.org//10.1016/j.cell.2014.03.008
- https://doi.org//10.1038/nature13182
- https://doi.org//10.1158/2159-8290.CD-11-0209
- https://doi.org//10.1126/science.1112014
- https://doi.org//10.1038/nrg2521
- https://doi.org//10.1016/j.cell.2009.02.006
- https://doi.org//10.1038/nature21374
- https://doi.org//10.1126/science.1112009
- https://doi.org//10.1038/nrm2738
- https://doi.org//10.1101/gr.132159.111
- https://doi.org//10.1101/gr.115469.110
- https://doi.org//10.1038/nbt.3947
- https://doi.org//10.1016/j.dnarep.2015.09.015
- https://doi.org//10.2174/1566524016666160316152147
- https://doi.org//10.1126/science.293.5532.1133
- https://doi.org//10.1016/j.bbagrm.2009.08.009
- https://doi.org//10.1016/j.bbagrm.2009.09.001
- https://doi.org//10.1016/j.febslet.2004.08.013
- https://doi.org//10.1038/nrc2271
- https://doi.org//10.1083/jcb.200512110
- https://doi.org//10.3892/ijo.32.2.289
- https://doi.org//10.1007/s12015-009-9078-9
- https://doi.org//10.1158/0008-5472.CAN-12-3848
- https://doi.org//10.18632/oncotarget.1136
- https://doi.org//10.18632/oncotarget.4236
- https://doi.org//10.1074/mcp.M115.050401
- https://doi.org//10.1016/j.bbcan.2018.03.001
- https://doi.org//10.3390/cancers11081105
- https://doi.org//10.1186/s13046-019-1307-8
- https://doi.org//10.1158/0008-5472.CAN-06-4325
- https://doi.org//10.1016/j.cell.2008.11.026
- https://doi.org//10.1073/pnas.1421197112
- https://doi.org//10.1007/s00109-019-01789-7
- https://doi.org//10.1038/s41467-019-11910-6
- https://doi.org//10.1093/nar/gkl1106
- https://doi.org//10.1007/s00427-017-0581-8
- https://doi.org//10.1080/15476286.2015.1060395
- https://doi.org//10.1093/nar/gkx247
- https://doi.org//10.1186/s13059-014-0560-6
- https://doi.org//10.1038/cr.2014.104
- https://doi.org//10.1093/nar/gkt006
- https://doi.org//10.1097/MPA.0b013e3181c15963
- https://doi.org//10.1371/journal.pone.0013002
- https://doi.org//10.1016/j.pan.2019.01.010
- https://doi.org//10.1371/journal.pone.0010431
- https://doi.org//10.1038/sj.bjc.6601391
- https://doi.org//10.2353/ajpath.2009.080523
- https://doi.org//10.1007/s13277-015-4625-2
- https://doi.org//10.1016/j.bbrc.2018.08.155
- https://doi.org//10.1016/j.bbagrm.2014.08.012
- https://doi.org//10.1111/cas.13642
- https://doi.org//10.3389/fmed.2015.00015
- https://doi.org//10.1186/1476-4598-10-8
- https://doi.org//10.1016/j.celrep.2015.05.008
- https://doi.org//10.1093/nar/gku1293
- https://doi.org//10.1111/j.1365-2559.2011.04121.x
- https://doi.org//10.2302/kjm.47.73
- https://doi.org//10.1016/j.bbagrm.2009.11.007
- https://doi.org//10.3389/fmed.2015.00039
- https://doi.org//10.3389/fgene.2017.00031
- https://doi.org//10.1101/gad.1540407
- https://doi.org//10.1371/journal.pgen.1007802
- https://doi.org//10.1007/s12035-018-1465-2
- https://doi.org//10.1016/j.bbagrm.2009.11.013
- https://doi.org//10.1016/j.diff.2013.02.001
- https://doi.org//10.1089/scd.2013.0600
- https://doi.org//10.1042/bse0540091
- https://doi.org//10.4161/epi.5.8.12996
- https://doi.org//10.1038/onc.2010.568
- https://doi.org//10.1016/j.tig.2012.03.013
- https://doi.org//10.1016/j.tig.2005.04.009
- https://doi.org//10.1534/genetics.106.069484
- https://doi.org//10.1074/jbc.275.15.11507
- https://doi.org//10.1101/gad.455708
- https://doi.org//10.1038/nm1784
- https://doi.org//10.3390/ijms19010123
- https://doi.org//10.1101/gad.1654808
- https://doi.org//10.1038/nature11508
- https://doi.org//10.1002/0471250953.bi1202s04
- https://doi.org//10.1093/nar/gkn188